The future magnitude of urological symptoms in the USA: projections using the Boston Area Community Health survey

The future magnitude of urological symptoms in the USA: projections using the Boston Area Community Health survey
复制标题

DOI:
10.1111/j.1464-410x.2007.07018.x
复制
发表时间:
2007-10-01
期刊:
影响因子:
4.5
通讯作者:
McKinlay, John B.
McKinlay, John B.
中科院分区:
医学2区
文献类型:
--
作者:
Litman, Heather J.;McKinlay, John B.

文献摘要

被引文献

相似文献

目的利用波士顿地区社区卫生调查(BACH)的数据,估计2025年美国人群泌尿系统症状的患病率,因为卫生服务研究人员使用疾病可能严重程度的预测来为未来卫生资源分配的决策提供信息。将BACH的特定患病率与美国人口预测相结合,以估计下尿路症状(LUTS)和提示尿漏的症状的可能程度,膀胱疼痛综合征(PBIS)和前列腺炎(仅男性)。结果在2025年,美国总共有5200万成年人将具有LUTS、尿漏、PBIS或前列腺炎的症状。这些泌尿系统的症状有很大的影响,对身体和精神方面的生活质量,这是可比的其他慢性conditions.ConclusionThe未来的幅度的症状表明这四个泌尿系统的条件可能会达到目前的水平,心血管疾病在美国,这被认为是“一个现代流行病。“我们的预测对医学教育、医疗服务提供者的培训、卫生服务研究以及政策和患者教育具有重要意义。
ObjectiveTo use the population-based data from the Boston Area Community Health (BACH) Survey to estimate the likely magnitude (prevalence) of urological symptoms in the USA population in 2025, as health-services researchers use projections of the likely magnitude of disease to inform decisions on the future allocation of health resources.Patients and MethodsAge and gender-specific prevalence rates from BACH were combined with USA population projections to estimate the likely magnitude of lower urinary tract symptoms (LUTS) and symptoms suggestive of urine leakage, painful bladder syndrome (PBlS) and prostatitis (men only).ResultsIn total and accounting for overlapping symptoms, 52 million adults in the USA will have symptoms of LUTS, urine leakage, PBlS or prostatitis in 2025. These urological symptoms have a large impact on physical and mental aspects of quality of life, that is comparable to other chronic conditions.ConclusionThe future magnitude of symptoms indicative of these four urological conditions might reach the current level of cardiovascular disease in the USA, which is considered 'a modern epidemic.' Our projections have important implications for medical education, training of healthcare providers, health-services research, and policy and patient education.